arrow
S

Susie M. Collins

Pfizer
H指数:10
被引数:980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapy

一线治疗期间晚期非小细胞肺癌患者体重和身体成分增加的频率

2024-09-171
OA
Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study

庞塞格罗玛单抗(ponsegromab)的疗效和安全性评估:该药物为一种首创的单克隆抗体抑制剂,可抑制生长分化因子15,用于癌症恶病质患者的研究:一项随机、安慰剂对照的II期临床试验

2024-09-010
PRE
Body composition and lung cancer-associated cachexia in TRACERx

TRACERx中的身体成分和肺癌相关的恶病质

2023-04-1233
OAAI
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates

GDF-15中和减轻了基于铂的化疗引起的小鼠和非人灵长类动物的呕吐,厌食和体重减轻

2020-12-0199
OAAI
Growth differentiation factor 15 (GDF-15) inhibition attenuates platinum-based chemotherapy-induced emesis, anorexia and weight loss and increases survival
2020-08-150
PRE